Ashfaq Marghoob provides skin cancer ... tissue and may be used to treat actinic keratosis. Because topical chemotherapy does not kill cells under the surface of the skin, close follow-up is essential ...

Post-treatment evaluations showed that the immunotherapy eliminated 95% of pre-cancerous spots on subjects' faces.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...

Talimogene laherparepvec is under clinical development by Amgen and currently in Phase II for Soft Tissue Sarcoma.

Surgical, radiation and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of head and neck squamous cell ...

The Hallmark actor known for roles in "Believe in Christmas" and the TV series "Hudson & Rex" thanked his family and medical ...